BACKGROUND: Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood, but occurs infrequently in infants (<1 year). Historically, infants with RMS have worse overall survival compared to other pediatric age groups. AIM: This study aims to assess the clinical features and treatment factors associated with survival comparing infants to children aged 1-9 years diagnosed with RMS. METHODS: Children aged <10 years diagnosed with RMS between 2000 and 2016 were identified using the SEER database. Descriptive statistics were used to assess demographic, clinical, and treatment characteristics of infants and children with RMS. Kaplan-Meier estimates and Cox proportional hazards regression were performed to assess for factors a...
Background: The prognosis of rhabdomyosarcoma (RMS) in children and adolescents has improved since t...
AimPositive outcomes for paediatric rhabdomyosarcoma (RMS) were high in Sweden during the 1990s, but...
BACKGROUND: The prognosis of rhabdomyosarcoma (RMS) in children and adolescents has improved since t...
Background. Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma in children. Fifty percent...
Background: Infants (<12 months) with rhabdomyosarcoma have historically had poorer outcome than the...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
BACKGROUND. Evidence from clinical trials has documented improvements in event-free survival from ch...
To provide a better insight into the epidemiology, characteristics, therapeutics, and outcomes of pe...
Purpose:Rhabdomyosarcoma (RMS) has a worse prognosis in adults than in children, but there is eviden...
Background: Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcomas (STS) in children. Even t...
BACKGROUND: The management of rhabdomyosarcoma (RMS) in patients age < 1 year is particularly proble...
Purpose: Rhabdomyosarcoma (RMS) is the most frequent soft tissue sarcoma in children. We have retros...
BACKGROUND: The management of rhabdomyosarcoma (RMS) in patients age < 1 year is particularly proble...
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction...
2019-04-24Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) are disproportionally represented in the...
Background: The prognosis of rhabdomyosarcoma (RMS) in children and adolescents has improved since t...
AimPositive outcomes for paediatric rhabdomyosarcoma (RMS) were high in Sweden during the 1990s, but...
BACKGROUND: The prognosis of rhabdomyosarcoma (RMS) in children and adolescents has improved since t...
Background. Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma in children. Fifty percent...
Background: Infants (<12 months) with rhabdomyosarcoma have historically had poorer outcome than the...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
BACKGROUND. Evidence from clinical trials has documented improvements in event-free survival from ch...
To provide a better insight into the epidemiology, characteristics, therapeutics, and outcomes of pe...
Purpose:Rhabdomyosarcoma (RMS) has a worse prognosis in adults than in children, but there is eviden...
Background: Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcomas (STS) in children. Even t...
BACKGROUND: The management of rhabdomyosarcoma (RMS) in patients age < 1 year is particularly proble...
Purpose: Rhabdomyosarcoma (RMS) is the most frequent soft tissue sarcoma in children. We have retros...
BACKGROUND: The management of rhabdomyosarcoma (RMS) in patients age < 1 year is particularly proble...
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction...
2019-04-24Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) are disproportionally represented in the...
Background: The prognosis of rhabdomyosarcoma (RMS) in children and adolescents has improved since t...
AimPositive outcomes for paediatric rhabdomyosarcoma (RMS) were high in Sweden during the 1990s, but...
BACKGROUND: The prognosis of rhabdomyosarcoma (RMS) in children and adolescents has improved since t...